Low miR-579-3p expression in BRAF-mutated cells is linked to metastatic melanoma progression; expression levels of miR-579-3p decrease from nevi to stage III/IV melanoma samples and even further in cell lines resistant to BRAF/MEK inhibitors. The gene discussed is BRAF; the disease is metastatic melanoma.